VITAS Innovative Hospice Care® of New Jersey West Names Patricia Claybrook Director of Market Development
Print a friendly version of this page

Mount Laurel, New Jersey, June 4, 2007—Patricia Claybrook of Medford has been appointed director of market development for VITAS Innovative Hospice Care® of New Jersey West, overseeing sales, recruitment and training of representatives, developing and implementing department goals and maintaining contact with referral sources.

Claybrook comes to VITAS after several years at the Saddle River branch of AstraZeneca Pharmaceuticals. She has an extensive sales background, with more than a decade in pharmaceutical sales divided between Abbott Laboratories in Illinois and Aventis Pharmaceuticals in New Jersey.

Claybrook has a bachelor’s degree in sociology from Franklin and Marshall College in Lancaster, Pennsylvania.

VITAS Innovative Hospice Care® is the nation’s largest provider of end-of-life care. A pioneer and leader in the hospice movement since 1978, VITAS has been caring for the terminally ill and their families in New Jersey since 2002.
____________________________________________________________________

With an average daily census that has grown to more than 11,000 patients, VITAS is the nation's largest hospice provider. Headquartered in Miami, Florida, VITAS employs more than 9.000 people and serves patients from 42 licensed programs in major metropolitan markets in 17 states—Arizona, California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Kansas, Michigan, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin.
____________________________________________________________________